Certified by Founder Lodge
bit.bio
United States - Cambridge, Cambridgeshire
START UP
1 Disclosed Funding Rounds $103,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology.
Our current focus is t
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 05 ,2021 | Series B | $103,000,000 | |
| January, 14 ,2026 | Unknown | $50,000,000.00 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
